Roles of molecular chaperones in protein misfolding diseases

José M. Barral, Sarah A. Broadley, Gregor Schaffar, F. Ulrich Hartl

Research output: Contribution to journalArticle

226 Citations (Scopus)

Abstract

Human misfolding diseases result from the failure of proteins to reach their active state or from the accumulation of aberrantly folded proteins. The mechanisms by which molecular chaperones influence the development of these diseases is beginning to be understood. Mutations that compromise the activity of chaperones lead to several rare syndromes. In contrast, the more frequent amyloid-related neurodegenerative diseases are caused by a gain of toxic function of misfolded proteins. Toxicity in these disorders may result from an imbalance between normal chaperone capacity and production of dangerous protein species. Increased chaperone expression can suppress the neurotoxicity of these molecules, suggesting possible therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)17-29
Number of pages13
JournalSeminars in Cell and Developmental Biology
Volume15
Issue number1
DOIs
StatePublished - Feb 2004
Externally publishedYes

Fingerprint

Proteostasis Deficiencies
Molecular Chaperones
Proteins
Poisons
Amyloid
Neurodegenerative Diseases
Mutation

Keywords

  • Amyloid
  • Misfolding diseases
  • Molecular chaperones
  • Polyglutamine diseases
  • Ubiquitin-proteasome system

ASJC Scopus subject areas

  • Developmental Biology

Cite this

Roles of molecular chaperones in protein misfolding diseases. / Barral, José M.; Broadley, Sarah A.; Schaffar, Gregor; Hartl, F. Ulrich.

In: Seminars in Cell and Developmental Biology, Vol. 15, No. 1, 02.2004, p. 17-29.

Research output: Contribution to journalArticle

Barral, José M. ; Broadley, Sarah A. ; Schaffar, Gregor ; Hartl, F. Ulrich. / Roles of molecular chaperones in protein misfolding diseases. In: Seminars in Cell and Developmental Biology. 2004 ; Vol. 15, No. 1. pp. 17-29.
@article{50d2f4fe63904af4b7ff2cfc3439568a,
title = "Roles of molecular chaperones in protein misfolding diseases",
abstract = "Human misfolding diseases result from the failure of proteins to reach their active state or from the accumulation of aberrantly folded proteins. The mechanisms by which molecular chaperones influence the development of these diseases is beginning to be understood. Mutations that compromise the activity of chaperones lead to several rare syndromes. In contrast, the more frequent amyloid-related neurodegenerative diseases are caused by a gain of toxic function of misfolded proteins. Toxicity in these disorders may result from an imbalance between normal chaperone capacity and production of dangerous protein species. Increased chaperone expression can suppress the neurotoxicity of these molecules, suggesting possible therapeutic strategies.",
keywords = "Amyloid, Misfolding diseases, Molecular chaperones, Polyglutamine diseases, Ubiquitin-proteasome system",
author = "Barral, {Jos{\'e} M.} and Broadley, {Sarah A.} and Gregor Schaffar and Hartl, {F. Ulrich}",
year = "2004",
month = "2",
doi = "10.1016/j.semcdb.2003.12.010",
language = "English (US)",
volume = "15",
pages = "17--29",
journal = "Seminars in Cell and Developmental Biology",
issn = "1084-9521",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Roles of molecular chaperones in protein misfolding diseases

AU - Barral, José M.

AU - Broadley, Sarah A.

AU - Schaffar, Gregor

AU - Hartl, F. Ulrich

PY - 2004/2

Y1 - 2004/2

N2 - Human misfolding diseases result from the failure of proteins to reach their active state or from the accumulation of aberrantly folded proteins. The mechanisms by which molecular chaperones influence the development of these diseases is beginning to be understood. Mutations that compromise the activity of chaperones lead to several rare syndromes. In contrast, the more frequent amyloid-related neurodegenerative diseases are caused by a gain of toxic function of misfolded proteins. Toxicity in these disorders may result from an imbalance between normal chaperone capacity and production of dangerous protein species. Increased chaperone expression can suppress the neurotoxicity of these molecules, suggesting possible therapeutic strategies.

AB - Human misfolding diseases result from the failure of proteins to reach their active state or from the accumulation of aberrantly folded proteins. The mechanisms by which molecular chaperones influence the development of these diseases is beginning to be understood. Mutations that compromise the activity of chaperones lead to several rare syndromes. In contrast, the more frequent amyloid-related neurodegenerative diseases are caused by a gain of toxic function of misfolded proteins. Toxicity in these disorders may result from an imbalance between normal chaperone capacity and production of dangerous protein species. Increased chaperone expression can suppress the neurotoxicity of these molecules, suggesting possible therapeutic strategies.

KW - Amyloid

KW - Misfolding diseases

KW - Molecular chaperones

KW - Polyglutamine diseases

KW - Ubiquitin-proteasome system

UR - http://www.scopus.com/inward/record.url?scp=0842303213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842303213&partnerID=8YFLogxK

U2 - 10.1016/j.semcdb.2003.12.010

DO - 10.1016/j.semcdb.2003.12.010

M3 - Article

C2 - 15036203

AN - SCOPUS:0842303213

VL - 15

SP - 17

EP - 29

JO - Seminars in Cell and Developmental Biology

JF - Seminars in Cell and Developmental Biology

SN - 1084-9521

IS - 1

ER -